MONOCLONAL IDIOTYPIC AND ANTIIDIOTYPIC ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN

被引:11
|
作者
BRODEUR, BR [1 ]
FAUCHER, S [1 ]
OSHAUGHNESSY, MV [1 ]
HAMEL, J [1 ]
机构
[1] FED CTR AIDS,OTTAWA,ONTARIO,CANADA
来源
JOURNAL OF GENERAL VIROLOGY | 1991年 / 72卷
关键词
D O I
10.1099/0022-1317-72-1-51
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Murine monoclonal antibodies (MAbs) gp41-1 (IgG2a) and gp41-2 (IgG1), directed against the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1), were produced and characterized. These MAbs recognized both gp160 and gp41 and reacted with divergent HIV-1 isolates. Surface binding assays using viable HIV-infected cells indicated that these MAbs were directed against surface-exposed epitopes. Both MAbs caused a reduction in reverse transcriptase activity. Syngeneic monoclonal anti-idiotypic antibodies (anti-ids) against gp41-1 were also generated. Six anti-ids (agp41-11 to agp41-16) were selected by ELISA using F(ab')2 fragments of gp41-1; no reaction was observed when fragments from an irrelevant IgG2a MAb were used. Anti-ids were recognized by both gp41-1 and gp41-2 biotinylated MAbs. Competitive ELISA studies suggested that anti-ids were directed against at least three distinct idiotopes on gp41-1. All anti-ids reacted with idiotopes associated with both heavy and light chains and not with separated chains. The binding of MAbs gp41-1 and gp41-2 to HlV-infected cells was inhibited by each anti-id, except for the binding of gp41-2 which was not affected by the presence of agp41-12. Immunization of rabbits with agp41-11 and agp41-13 resulted in an antibody response against recombinant gp160. These studies indicated that these two anti-ids contain a surrogate image of the antigen recognized by gp41-1.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [1] FUNCTIONAL REGIONS OF THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    KOWALSKI, M
    POTZ, J
    BASIRIPOUR, L
    DORFMAN, T
    WEI, CG
    TERWILLIGER, E
    DAYTON, A
    ROSEN, C
    HASELTINE, W
    SODROSKI, J
    SCIENCE, 1987, 237 (4820) : 1351 - 1355
  • [2] DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN OLIGOMERIC STRUCTURE
    POUMBOURIOS, P
    ELAHMAR, W
    MCPHEE, DA
    KEMP, BE
    JOURNAL OF VIROLOGY, 1995, 69 (02) : 1209 - 1218
  • [3] SECRETION OF A TRUNCATED FORM OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN
    HALLENBERGER, S
    TUCKER, SP
    OWENS, RJ
    BERNSTEIN, HB
    COMPANS, RW
    VIROLOGY, 1993, 193 (01) : 510 - 514
  • [4] IMMUNOLOGICAL ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN PROTEOLYTIC CLEAVAGE
    FENOUILLET, E
    GLUCKMAN, JC
    VIROLOGY, 1992, 187 (02) : 825 - 828
  • [5] NATIVE OLIGOMERIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN ELICITS DIVERSE MONOCLONAL-ANTIBODY REACTIVITIES
    EARL, PL
    BRODER, CC
    LONG, D
    LEE, SA
    PETERSON, J
    CHAKRABARTI, S
    DOMS, RW
    MOSS, B
    JOURNAL OF VIROLOGY, 1994, 68 (05) : 3015 - 3026
  • [6] ROLE OF THE MATRIX PROTEIN IN THE VIRION ASSOCIATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN
    DORFMAN, T
    MAMMANO, F
    HASELTINE, WA
    GOTTLINGER, HG
    JOURNAL OF VIROLOGY, 1994, 68 (03) : 1689 - 1696
  • [7] EFFECT OF A GLUCOSIDASE INHIBITOR ON THE BIOACTIVITY AND IMMUNOREACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN
    FENOUILLET, E
    GLUCKMAN, JC
    JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1919 - 1926
  • [8] THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STIMULATES RELEASE OF NEUROTOXINS FROM MONOCYTES
    GIULIAN, D
    WENDT, E
    VACA, K
    NOONAN, CA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 2769 - 2773
  • [9] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN IS MODIFIED BY O-LINKED OLIGOSACCHARIDES
    BERNSTEIN, HB
    TUCKER, SP
    HUNTER, E
    SCHUTZBACH, JS
    COMPANS, RW
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 463 - 468
  • [10] DISTINCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION AND INFECTION ENHANCEMENT BY HUMAN MONOCLONAL-ANTIBODIES TO GLYCOPROTEIN-120
    TAKEDA, A
    ROBINSON, JE
    HO, DD
    DEBOUCK, C
    HAIGWOOD, NL
    ENNIS, FA
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06): : 1952 - 1957